Jubilant Ingrevia's Stock Price Soars 5.07% on Strong Performance and 'Hold' Recommendation from MarketsMOJO
Jubilant Ingrevia, a midcap pharmaceutical company, saw a 5.07% increase in its stock price on November 29, 2024, outperforming the sector by 2.77%. With a 'Hold' recommendation from MarketsMojo, the company's consistent trading above its moving averages and positive growth in the pharmaceutical sector make it a promising stock to watch.
Jubilant Ingrevia, a midcap pharmaceutical company, saw a 5.07% increase in its stock price on November 29, 2024. This outperformed the sector by 2.77%, with the stock reaching an intraday high of Rs 778.75. The company's stock has been consistently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
According to MarketsMOJO, a leading stock analysis and recommendation platform, the stock call for Jubilant Ingrevia is 'Hold'. This is based on the company's recent performance and market trends. The pharmaceutical and drugs sector has also seen a positive growth of 2.3%.
In comparison to the overall market performance, Jubilant Ingrevia has shown a strong 1-day and 1-month performance, with a 5.09% and 14.05% increase respectively. This is significantly higher than the Sensex's performance of 0.96% and -0.71% for the same time periods.
Jubilant Ingrevia continues to make strides in the pharmaceutical industry, with its stock price reflecting its strong performance and potential for growth. With a 'Hold' recommendation from MarketsMOJO, investors can keep a close eye on this midcap company as it continues to make its mark in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
